Loblaw Companies Limited · TSX:L
Loblaw Companies — Q1 2024 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Mar 23, 2024
Slide 1: Supplementary Slides Q1 2024
SUPPLEMENTARY SLIDES Q1 2024 For the periods ended March 23, 2024 and March 25, 2023 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q1 2024 (millions of Canadian dollars unless otherwise noted) Q1 2024 Q1 2023 % Change (1) Consolidated Revenue $13,581 $12,995 ↑ +4.5% Adjusted EBITDA $1,544 $1,448 ↑ +6.6% Adjusted EBITDA Margin 11.4 % 11.1 % ↑ 30bps Adjusted Net Earnings Avaliable to Common Sh
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q1 2024 (millions of Canadian dollars unless otherwise noted) Q1 2024 Q1 2023 % Change (1) Total Retail Revenue $13,290 $12,735 ↑ 4.4% Retail Revenue - Food $9,409 $9,011 ↑ 4.4% Retail Revenue - Drug $3,881 $3,724 ↑ 4.2% Pharmacy and Healthcare Services $2,059
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q1 2024 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +3.4% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +4.0